In ovarian cancer, Tregs were selectively recruited into the tumor tissue via CCL22 and CCL28 production by the tumor cells and subsequently, Treg-induced secretion of high amounts of VEGF-A to promote endothelial cell proliferation (118, 195). The gene discussed is CCL28; the disease is neoplasm.